Whether they are small quantities of APIs for initial development work or many kilograms for a late phase trial, BOC Sciences whose reputation is built on excellence in chemistry can raise the bar on quality.
New York, USA – August 4, 2022 – At BOC Sciences, both non-GMP & GMP manufacturing of APIs are available to solve any API development challenges. Its production capabilities range from pilot to commercial scales, offering multitudinous options of materials for pre-clinical, IND, and early clinical trials.
It's publicly noted that conditions in large-scale production are more complex than that in small scales. And after the pilot scale-up, when entering the commercial production stage, many of BOC Sciences' peers indeed encounter problems caused by the amplification effect. Fortunately, BOC Sciences has found its way to handle this issue by optimizing the scale-up technologies and process.
As for biotech companies, advanced and complete infrastructure is the basis for all R&D activities. BOC Sciences, after years of improvement, is well prepared in this regard. Its production workshops have a total area of more than 6000 square feet, with a series of reactors spanning from 50L to 2000L and multiple drug product (DP) filling production lines.
Beyond the above abilities, BOC Sciences has a set of well-designed facilities to control contamination:
* The scientific and flexible flow line design can significantly reduce cross-contamination in the manufacturing process, and in the meantime, satisfy the requirements of API custom development and manufacturing .
* Three-stage filtration systems are established in the clean room area while air showers are set at the entrance. Separate fresh air, return air, and exhaust systems are utilized in different clean rooms with a view to inhibiting or minimizing the possibilities of contamination.
Currently, with the mature chemical synthesis technologies and cutting-edge infrastructure, BOC Sciences' comprehensive platforms extend to develop High Potency APIs (HPAPI). HPAPIs occupy a weighty portion in the development of small molecule drugs and they have validated curative effects in cancer and many other diseases.“We are now competent to quickly conduct scale-up production of HPAPIs, which is a significant breakthrough motivating our further innovation,” said the BOC Sciences chief technician.
BOC Sciences is currently getting close to its destination of becoming a respected CDMO. ADCs, APIs & intermediates, labeled compounds, lipids, etc., most of the molecules can be customized in the pioneering R&D labs and GMP complied production lines. It supports a variety of cooperation models, indicating that customers can finally obtain satisfactory results if partnering with BOC Sciences.
BOC Sciences can provide non-GMP/GMP pilot and commercial scale solutions to satisfy customers' demands on APIs. As a global leader in chemical manufacturing solutions, BOC Sciences has experienced employees, large-scale production plants, and advanced equipment, which can provide excellent results and quality assurance for far-ranging projects.
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.